Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany

INTRODUCTION: The COVID-19 pandemic has entered its third year and continues to affect most countries worldwide. Active surveillance, i.e. testing individuals irrespective of symptoms, presents a promising strategy to accurately measure the prevalence of SARS-CoV-2. We aimed to identify the most cos...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Hoa Thi, Denkinger, Claudia M., Brenner, Stephan, Koeppel, Lisa, Brugnara, Lucia, Burk, Robin, Knop, Michael, Bärnighausen, Till, Deckert, Andreas, De Allegri, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850332/
https://www.ncbi.nlm.nih.gov/pubmed/36656403
http://dx.doi.org/10.1007/s10198-022-01561-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850332/
https://www.ncbi.nlm.nih.gov/pubmed/36656403
http://dx.doi.org/10.1007/s10198-022-01561-8

Ejemplares similares